--- title: | Clinical Trends & Insights description: Clinical Trends & Insights | --- [![Elixir_Logo_Tag](https://visiblydifferent.envisionrx.com/hubfs/Elixir_Logo_Tag.png "Elixir_Logo_Tag")](http://www.elixirsolutions.com) #### [Choice of Specialty Pharmacy Can Impact Specialty Drug Spend](https://blog.elixirsolutions.com/choice-of-specialty-pharmacy-can-impact-specialty-drug-spend) ** [Clinical Trends & Insights](https://blog.elixirsolutions.com/tag/clinical-trends-insights) Payers can better manage specialty drug costs if they take a close look at the specialty pharmacies their members are... [Read More](https://blog.elixirsolutions.com/choice-of-specialty-pharmacy-can-impact-specialty-drug-spend) [![Pharmacist holding medication](https://blog.elixirsolutions.com/hubfs/Blog%20Images/Blog%20Feature%20Images/pharmacist_female_medication_specialty.jpg) ](https://blog.elixirsolutions.com/choice-of-specialty-pharmacy-can-impact-specialty-drug-spend) #### [Unmasking the Medications You Shouldn’t Be Paying For](https://blog.elixirsolutions.com/unmasking-the-medications-you-shouldnt-be-paying-for) ** [Clinical Trends & Insights](https://blog.elixirsolutions.com/tag/clinical-trends-insights), ** [Industry Updates](https://blog.elixirsolutions.com/tag/industry-updates) Hundreds of prescription medications process every day and patients and plan sponsors pay for them because that's what... [Read More](https://blog.elixirsolutions.com/unmasking-the-medications-you-shouldnt-be-paying-for) [![](https://blog.elixirsolutions.com/hubfs/Blog%20Images/Blog%20Feature%20Images/medications.jpg) ](https://blog.elixirsolutions.com/unmasking-the-medications-you-shouldnt-be-paying-for) #### [NASH: The growing and costly disease you probably don’t know about but should](https://blog.elixirsolutions.com/nash-the-growing-and-costly-disease-you-probably-dont-know-about-but-should) ** [Clinical Trends & Insights](https://blog.elixirsolutions.com/tag/clinical-trends-insights), ** [Trends & Insights](https://blog.elixirsolutions.com/tag/trends-insights) Nonalcoholic steatohepatitis (NASH) is a type of nonalcoholic fatty liver disease (NAFLD). Like its name states, NASH... [Read More](https://blog.elixirsolutions.com/nash-the-growing-and-costly-disease-you-probably-dont-know-about-but-should) [![Woman Mixing Batter](https://blog.elixirsolutions.com/hubfs/Blog%20Images/Blog%20Feature%20Images/iStock-1382212724-mixing%20batter-female-diverse-1.jpg) ](https://blog.elixirsolutions.com/nash-the-growing-and-costly-disease-you-probably-dont-know-about-but-should) #### [Four Strategies to Successfully Manage Specialty Medications](https://blog.elixirsolutions.com/four-strategies-specialty-medications) ** [Solutions & Best Practices](https://blog.elixirsolutions.com/tag/solutions-best-practices), ** [Clinical Trends & Insights](https://blog.elixirsolutions.com/tag/clinical-trends-insights) While specialty medications provide a new level of hope for people being treated for serious conditions such as... [Read More](https://blog.elixirsolutions.com/four-strategies-specialty-medications) [![](https://blog.elixirsolutions.com/hubfs/Blog%20Images/Blog%20Feature%20Images/looking%20for%20medication_specialty_pharmacist_fade.jpg) ](https://blog.elixirsolutions.com/four-strategies-specialty-medications) #### [New Guidelines for Diabetes First Line Therapy Could Lead to Increases in Drug Spend](https://blog.elixirsolutions.com/new-guidelines-for-diabetes-first-line-therapy) ** [Clinical Trends & Insights](https://blog.elixirsolutions.com/tag/clinical-trends-insights), ** [Industry Updates](https://blog.elixirsolutions.com/tag/industry-updates) Diabetes is an epidemic that drives a significant amount of medical cost. Eleven percent of the United States’... [Read More](https://blog.elixirsolutions.com/new-guidelines-for-diabetes-first-line-therapy) [![](https://blog.elixirsolutions.com/hubfs/Diabetes%20iStock-1185738340.jpg) ](https://blog.elixirsolutions.com/new-guidelines-for-diabetes-first-line-therapy) #### [What to Know for the 2022-2023 Flu Season](https://blog.elixirsolutions.com/what-to-know-for-the-2022-2023-flu-season) ** [Clinical Trends & Insights](https://blog.elixirsolutions.com/tag/clinical-trends-insights), ** [Industry Updates](https://blog.elixirsolutions.com/tag/industry-updates) According to the Centers for Disease Control and Prevention (CDC), there were as many as 14,000 flu-related deaths and... [Read More](https://blog.elixirsolutions.com/what-to-know-for-the-2022-2023-flu-season) [![](https://blog.elixirsolutions.com/hubfs/Woman%20Young%20Sick%20Flu%20Couch%20Fever%20Blanket%20iStock-1175000095.jpg) ](https://blog.elixirsolutions.com/what-to-know-for-the-2022-2023-flu-season) #### [Biosimilars Versus Interchangeability: What You Need to Know](https://blog.elixirsolutions.com/biosimilars-versus-interchangeability) ** [Clinical Trends & Insights](https://blog.elixirsolutions.com/tag/clinical-trends-insights) Specialty medications continue to be a large source of drug spend, in particular biologic drugs. Biosimilars pose an... [Read More](https://blog.elixirsolutions.com/biosimilars-versus-interchangeability) [![](https://blog.elixirsolutions.com/hubfs/Blog%20Images/Biosimilars-Part-2-Blog-Photo.png) ](https://blog.elixirsolutions.com/biosimilars-versus-interchangeability) #### [Demonstrating the Value of Specialty Medications that Treat Cystic Fibrosis](https://blog.elixirsolutions.com/cystic-fibrosis-kpi) ** [Clinical Trends & Insights](https://blog.elixirsolutions.com/tag/clinical-trends-insights) Cystic fibrosis (CF) is a rare genetic disorder that affects one in 3,900 live births. There are approximately 30,000... [Read More](https://blog.elixirsolutions.com/cystic-fibrosis-kpi) [![](https://blog.elixirsolutions.com/hubfs/Blog%20Images/CF7.png) ](https://blog.elixirsolutions.com/cystic-fibrosis-kpi) #### [Demonstrating the Value of Specialty Medications that Treat Various Cancers](https://blog.elixirsolutions.com/oncology-kpi) ** [Clinical Trends & Insights](https://blog.elixirsolutions.com/tag/clinical-trends-insights) Approximately 40% of Americans will be diagnosed with some type of cancer in their lifetime. Many cancer treatments... [Read More](https://blog.elixirsolutions.com/oncology-kpi) [![](https://blog.elixirsolutions.com/hubfs/Blog%20Images/Oncology%20KPI%20Blog%20Photo.jpg) ](https://blog.elixirsolutions.com/oncology-kpi) #### [Demonstrating the Value of Specialty Medications that Treat Multiple Sclerosis](https://blog.elixirsolutions.com/ms-kpi) ** [Clinical Trends & Insights](https://blog.elixirsolutions.com/tag/clinical-trends-insights) There is no cure for the debilitating disease multiple sclerosis (MS); however, there are treatments that can slow... [Read More](https://blog.elixirsolutions.com/ms-kpi) [![](https://blog.elixirsolutions.com/hubfs/Blog%20Images/MS-KPI-1.jpg) ](https://blog.elixirsolutions.com/ms-kpi) 1 [2 ](https://blog.elixirsolutions.com/tag/clinical-trends-insights/page/2) [** ](https://blog.elixirsolutions.com/tag/clinical-trends-insights/page/2) ### Post By Topic - [Clinical Trends & Insights (17)](https://blog.elixirsolutions.com/tag/clinical-trends-insights) - [Getting to know Elixir (7)](https://blog.elixirsolutions.com/tag/getting-to-know-elixir) - [Industry Updates (20)](https://blog.elixirsolutions.com/tag/industry-updates) - [Perspective on the Rx Pipeline (13)](https://blog.elixirsolutions.com/tag/perspective-on-the-rx-pipeline) - [Solutions & Best Practices (22)](https://blog.elixirsolutions.com/tag/solutions-best-practices) - [Trends & Insights (3)](https://blog.elixirsolutions.com/tag/trends-insights) [See all](https://blog.elixirsolutions.com/tag/clinical-trends-insights#) ### Receive Insights in your Inbox [elixirsolutions.com](https://www.elixirsolutions.com/) [![Share on linkedin](https://blog.elixirsolutions.com/hs-fs/hubfs/Root/Social%20Icons/linkedin-color.png?width=24&name=linkedin-color.png) ](https://www.linkedin.com/company/elixir-craftedrxsolutions/) [![Share on twitter](https://blog.elixirsolutions.com/hs-fs/hubfs/Root/Social%20Icons/twitter-color.png?width=24&name=twitter-color.png) ](https://twitter.com/ElixirPBM) ## [TERMS OF USE](https://www.elixirsolutions.com/home/terms-of-use)          [PRIVACY POLICY ](https://www.elixirsolutions.com/home/privacy-policy)         [PRIVACY NOTICE](https://www.elixirsolutions.com/home/privacy-notice)         [ NON-DISCRIMINATION POLICY](https://www.elixirsolutions.com/home/non-discrimination-policy) ## © 2026 Elixir All rights reserved